| Previous Close | $144.77 |
|---|---|
| Open | $144.98 |
| Day's Range | $143.13-$145.80 |
| 52 Week Range | $143.13-$175.97 |
| Volume | 9,887,704 |
| Avg Vol (30 day) | 7,417,568 |
| Last Time | 16:00:02 EDT |
| Last Size | _NA_ |
| Short Interest | 2.29233% |
| Beta | 0.526309 |
|---|---|
| Market Cap | 348.86 B |
| Shares Outstanding | 2.41 B |
| EPS | 7.86 |
| P/E Ratio | 18.55 |
| Div Per Share | 4.70 |
| Dividend Yield | 3.29 |
| Ex-Dividend Date | 05/20/2024 |
| Next Earnings Release Date | n/a |
- Quotes for this stock by Timeframe:
- Today updates page content
- /
- 1 Week updates page content
- /
- 3 Month selected
- /
- 1 Year updates page content
Recent Headlines
Wednesday's ETF with Unusual Volume: IHE
As of 12:40 PM EDT 04/17/2024 - ComtexApr 17, 2024 (MarketNewsVideo.com via COMTEX News Network) --
Company Profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Johnson & Johnson,
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
Phone: 1.732.524.0400 Fax: n/a
| Industry | Pharmaceuticals: Major |
|---|---|
| Sector | Health Technology |
| Website | www.jnj.com |
| Employees | 131,900 |
| CEO | Mr. Joaquin Duato |
